Wockhardt Ltd

NSE: WOCKPHARMA · BSE: 532300 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹2,137.20
Market cap: ₹34,728 Cr
Revenue (annual): ₹3,373 Cr
Net profit (annual): ₹213.0 Cr
P/E (TTM): 84.9×Sector 47.4×
Promoter holding: 49.08%+0.00% QoQ
FII holding: 7.23%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Date 5 Other Announcement 4 Annual General Meeting 4 Financial Results 3 Management Change 2 Legal & Regulatory 2 Earnings Call 2 Business Update 2 Results Update 1 Regulatory Approval 1 Fund Raise 1 Credit Rating 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 May 2026 09:16 IST BSE

Regulatory Approval

Wockhardt Regulatory Approval

Wockhardt received CDSCO marketing authorization for its breakthrough antibiotic, ZAYNICH, in India. The drug targets complicated urinary tract infections, addressing significant unmet medical needs in antibiotic resistance.

Read the filing ↗